Funder
Biological and Environmental Research
National Institutes of Health
U.S. Department of Energy
National Institute of Allergy and Infectious Diseases
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference42 articles.
1. Characteristics of SARS-CoV-2 and COVID-19;Hu;Nat. Rev. Microbiol.,2021
2. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape;Tregoning;Nat. Rev. Immunol.,2021
3. SARS-CoV-2 antiviral therapy;Tao;Clin. Microbiol. Rev.,2021
4. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses;Lancet,2022
5. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial;Ader;Lancet Infect. Dis.,2022
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献